Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Zosano Pharma Corp
| Metric | Zosano Pharma Corp Healthcare |
|---|---|
| Quality Score | 55 / 100 |
| Revenue (latest) | $785,000 |
| Net income (latest) | −$30M |
| Operating margin | −4016.8% |
| Net margin | −3812.1% |
| Return on equity | −90.8% |
| Return on assets | −61.8% |
| Return on capital (ROCE) | −84.6% |
| Debt / equity | 0.47× |
| Revenue growth (YoY) | 250.4% |
| Altman Z″ (distress) | -26.46 |
| Accruals / assets | −4.8% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.